Tarsus Pharmaceuticals Inc Financial Flexibility Index
Tarsus Pharmaceuticals Inc financial flexibility index. Tarsus Pharmaceuticals Inc (TARS) has a Financial Flexibility Index of 0.27x as of June 2026. Free cash flow of $70.84 Million (operating CF $66.77 Million minus capex $4.07 Million) represents 0% of total liabilities ($264.41 Million). See Tarsus Pharmaceuticals Inc (TARS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tarsus Pharmaceuticals Inc (2018–2025)
Financial flexibility index of Tarsus Pharmaceuticals Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Tarsus Pharmaceuticals Inc across 8 annual periods. Check TARS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Tarsus Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2025)
Tarsus Pharmaceuticals Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Tarsus Pharmaceuticals Inc. For the full cash flow conversion analysis, see TARS operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-2.59 Million | $-12.45 Million | $218.73 Million | ▲ +97.8% |
| 2024 | -0.53x | $-81.46 Million | $-83.03 Million | $152.46 Million | ▲ +67.3% |
| 2023 | -1.63x | $-111.99 Million | $-117.49 Million | $68.50 Million | ▼ -17.8% |
| 2022 | -1.39x | $-48.52 Million | $-49.03 Million | $34.96 Million | ▼ -489.9% |
| 2021 | 0.36x | $4.33 Million | $3.75 Million | $12.18 Million | ▲ +110.3% |
| 2020 | -3.45x | $-20.68 Million | $-21.14 Million | $5.99 Million | ▼ -6246.8% |
| 2019 | -0.05x | $-3.50 Million | $-3.67 Million | $64.32 Million | ▲ +82.7% |
| 2018 | -0.31x | $-1.18 Million | $-1.18 Million | $3.74 Million | — |